AbbVie
ABBV
#35
Rank
$382.49 B
Marketcap
$216.49
Share price
-2.14%
Change (1 day)
18.83%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Total debt

Total debt on the balance sheet as of March 2026 : $72.85 Billion USD

According to AbbVie's latest financial reports the company's total debt is $72.85 Billion USD. A companyโ€™s total debt is the sum of all current and non-current debts.

AbbVie - Total debt on balance sheet (from 2011 to 2026)

Total debt by year

Year Total debt Change
2025-12-31$67.49 B0.52%
2024-12-31$67.14 B13.07%
2023-12-31$59.38 B-6.14%
2022-12-31$63.27 B-17.49%
2021-12-31$76.68 B-10.89%
2020-12-31$86.05 B28.97%
2019-12-31$66.72 B65.54%
2018-12-31$40.31 B7.87%
2017-12-31$37.36 B1.43%
2016-12-31$36.84 B16.33%
2015-12-31$31.67 B111.46%
2014-12-31$14.97 B1.73%
2013-12-31$14.72 B-6.06%
2012-12-31$15.67 B32550%
2011-12-31$48 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Pfizer
PFE
$63.73 B-12.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$43.37 B-40.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
$57.32 B-21.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
$6.56 B-90.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
$22.17 B-69.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$46.42 B-36.28%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
$33.91 B-53.45%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
$25.23 B-65.36%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
$0.40 B-99.44%๐Ÿ‡บ๐Ÿ‡ธ USA